124 related articles for article (PubMed ID: 15252143)
1. Role of the transcription factor Ets-1 in cisplatin resistance.
Wilson LA; Yamamoto H; Singh G
Mol Cancer Ther; 2004 Jul; 3(7):823-32. PubMed ID: 15252143
[TBL] [Abstract][Full Text] [Related]
2. Ets-1 mRNA expression in effusions of serous ovarian carcinoma patients is a marker of poor outcome.
Davidson B; Risberg B; Goldberg I; Nesland JM; Berner A; Tropé CG; Kristensen GB; Bryne M; Reich R
Am J Surg Pathol; 2001 Dec; 25(12):1493-500. PubMed ID: 11717538
[TBL] [Abstract][Full Text] [Related]
3. Potential role of the HOXD8 transcription factor in cisplatin resistance and tumour metastasis in advanced epithelial ovarian cancer.
Sun P; Song Y; Liu D; Liu G; Mao X; Dong B; Braicu EI; Sehouli J
Sci Rep; 2018 Sep; 8(1):13483. PubMed ID: 30194340
[TBL] [Abstract][Full Text] [Related]
4. Influence of the proto-oncogene c-fos on cisplatin sensitivity.
Moorehead RA; Singh G
Biochem Pharmacol; 2000 Feb; 59(4):337-45. PubMed ID: 10644041
[TBL] [Abstract][Full Text] [Related]
5. DNA damage inducible-gene expression following platinum treatment in human ovarian carcinoma cell lines.
Delmastro DA; Li J; Vaisman A; Solle M; Chaney SG
Cancer Chemother Pharmacol; 1997; 39(3):245-53. PubMed ID: 8996528
[TBL] [Abstract][Full Text] [Related]
6. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
[TBL] [Abstract][Full Text] [Related]
7. The Ets family contains transcriptional activators and repressors involved in angiogenesis.
Lelièvre E; Lionneton F; Soncin F; Vandenbunder B
Int J Biochem Cell Biol; 2001 Apr; 33(4):391-407. PubMed ID: 11312108
[TBL] [Abstract][Full Text] [Related]
8. TET1 promotes cisplatin-resistance via demethylating the vimentin promoter in ovarian cancer.
Han X; Zhou Y; You Y; Lu J; Wang L; Hou H; Li J; Chen W; Zhao L; Li X
Cell Biol Int; 2017 Apr; 41(4):405-414. PubMed ID: 28150354
[TBL] [Abstract][Full Text] [Related]
9. Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma.
Davidson B; Reich R; Goldberg I; Gotlieb WH; Kopolovic J; Berner A; Ben-Baruch G; Bryne M; Nesland JM
Clin Cancer Res; 2001 Mar; 7(3):551-7. PubMed ID: 11297247
[TBL] [Abstract][Full Text] [Related]
10. HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells.
Ribeiro JR; Schorl C; Yano N; Romano N; Kim KK; Singh RK; Moore RG
J Ovarian Res; 2016 May; 9(1):28. PubMed ID: 27184254
[TBL] [Abstract][Full Text] [Related]
11. Resistance to chemotherapy-induced apoptosis via decreased caspase-3 activity and overexpression of antiapoptotic proteins in ovarian cancer.
Yang X; Zheng F; Xing H; Gao Q; Wei W; Lu Y; Wang S; Zhou J; Hu W; Ma D
J Cancer Res Clin Oncol; 2004 Jul; 130(7):423-8. PubMed ID: 15156398
[TBL] [Abstract][Full Text] [Related]
12. The epithelial-specific ETS transcription factor ESX/ESE-1/Elf-3 modulates breast cancer-associated gene expression.
Eckel KL; Tentler JJ; Cappetta GJ; Diamond SE; Gutierrez-Hartmann A
DNA Cell Biol; 2003 Feb; 22(2):79-94. PubMed ID: 12713734
[TBL] [Abstract][Full Text] [Related]
13. MZF1 possesses a repressively regulatory function in ERCC1 expression.
Yan QW; Reed E; Zhong XS; Thornton K; Guo Y; Yu JJ
Biochem Pharmacol; 2006 Mar; 71(6):761-71. PubMed ID: 16426580
[TBL] [Abstract][Full Text] [Related]
14. Cordycepin Resensitizes T24R2 Cisplatin-Resistant Human Bladder Cancer Cells to Cisplatin by Inactivating Ets-1 Dependent MDR1 Transcription.
Oh SS; Lee KW; Madhi H; Jeong JW; Park S; Kim M; Lee Y; Han HT; Hwangbo C; Yoo J; Kim KD
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32131547
[TBL] [Abstract][Full Text] [Related]
15. Ets up-regulates MET transcription.
Gambarotta G; Boccaccio C; Giordano S; Andŏ M; Stella MC; Comoglio PM
Oncogene; 1996 Nov; 13(9):1911-7. PubMed ID: 8934537
[TBL] [Abstract][Full Text] [Related]
16. Induction of tenascin-C by tumor-specific EWS-ETS fusion genes.
Watanabe G; Nishimori H; Irifune H; Sasaki Y; Ishida S; Zembutsu H; Tanaka T; Kawaguchi S; Wada T; Hata J; Kusakabe M; Yoshida K; Nakamura Y; Tokino T
Genes Chromosomes Cancer; 2003 Mar; 36(3):224-32. PubMed ID: 12557222
[TBL] [Abstract][Full Text] [Related]
17. STAT1 and Nmi are downstream targets of Ets-1 transcription factor in MCF-7 human breast cancer cell.
Jung HH; Lee J; Kim JH; Ryu KJ; Kang SA; Park C; Sung K; Nam DH; Kang WK; Park K; Im YH
FEBS Lett; 2005 Jul; 579(18):3941-6. PubMed ID: 15996661
[TBL] [Abstract][Full Text] [Related]
18. Expression of the ets-1 proto-oncogene in human colorectal carcinoma.
Nakayama T; Ito M; Ohtsuru A; Naito S; Sekine I
Mod Pathol; 2001 May; 14(5):415-22. PubMed ID: 11353051
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor receptor 4 is a target for the zinc-finger transcription factor Ikaros in the pituitary.
Yu S; Asa SL; Ezzat S
Mol Endocrinol; 2002 May; 16(5):1069-78. PubMed ID: 11981041
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of dihydrodiol dehydrogenase induces resistance to cisplatin in human ovarian carcinoma cells.
Deng HB; Parekh HK; Chow KC; Simpkins H
J Biol Chem; 2002 Apr; 277(17):15035-43. PubMed ID: 11842089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
